Vishwatma 1992 Full Movie Free Downloadgolkes

CLICK HERE … https://urlca.com/2sGDuw

Sunny Deol in Vishwatma (1992). See full cast ». The city of Nairobi is the setting for all parts of the movie that take place in Kenya, as revealed by the characters themselves. Yet in the song “Aankhon Mein Hai Kya”, the ocean is shown prominently even though Nairobi has an. movies movies all freeUniformity of transvaginal prostatic biopsy interpretation. To assess the reliability of prostatic cancer diagnosis obtained by transvaginal biopsies performed by different urologists at different times. The sensitivities and specificities of PSA, DRE, and transvaginal prostatic biopsies (TVP) were evaluated in a cross-sectional study of 1,934 males referred for evaluation of increased PSA. Biopsies were performed by five different urologists at three time intervals. There were 203 cases of confirmed cancer and 1,721 benign lesions. The sensitivity of PSA, DRE, and transvaginal biopsies was 37%, 63%, and 78%, respectively. The specificities were 84%, 81%, and 64%, respectively. For each tumor size category, the specificities of biopsy and PSA were similar, but for each group size of cancer, biopsy had a significantly higher specificity. The sensitivities of biopsy for cancer detection were significantly higher for those cases of only one small cancer lesion (10 mm or less) versus tumors less than 10 mm. The sensitivities for each lesion size ranged from 46% for tumors less than 10 mm, to 64% for tumors between 10 mm and 20 mm, to 93% for tumors greater than 20 mm. We concluded that the specificities and sensitivities of biopsy and PSA in screening for prostate cancer are similar, but that biopsy is significantly more specific than PSA for cancers less than 20 mm. Whether the additional specificity afforded by biopsy translates into a net overall benefit to cancer screening remains to be determined.Tumor-directed antibody therapy in ovarian cancer. Ovarian cancer is the leading cause of death from gynecologic cancer in the United States, and the most common cause of gynecologic cancer-related deaths in women. Despite this, there have been few therapeutic agents available to treat advanced ovarian cancer. Most clinical trials of experimental therapies for ovarian cancer have failed to show any significant therapeutic benefit, perhaps because the predominant primary site of disease in ovarian cancer is often not accessible for therapeutic intervention

0644bf28c6